Skip to Content

Francis deSouza

Francis DeSouza is the CEO of Illumina, the world’s dominant maker of gene sequencing technology. DeSouza is locked in a battle with the FTC over the re-acquisition of a company Illumina previously spun out, called GRAIL, that has a breakthrough cancer screening test.

“We know if we acquire GRAIL, tens of thousands of lives will be saved. That motivates us deeply.”

— Francis deSouza
francis_desouza
Featured in these episodes:
Francis deSouza, guest
August 19, 2021

The CEO of Illumina, Francis DeSouza, has been locked in a multi-year battle with the FTC over the re-acquisition of a company it previously spun out, called GRAIL, that has a breakthrough cancer screening test. He reflects on the lessons of grappling with regulators, highlighting levers that can help to accelerate scale.